• Aucun résultat trouvé

CD47 promotes age-associated deterioration in angiogenesis, blood flow and glucose homeostasis

N/A
N/A
Protected

Academic year: 2021

Partager "CD47 promotes age-associated deterioration in angiogenesis, blood flow and glucose homeostasis"

Copied!
4
0
0

Texte intégral

(1)

Cells 2020, 9, 1695; doi:10.3390/cells9071695 www.mdpi.com/journal/cells

Supplementary Materials

Supplementary Figure 1. Demographic characteristics of organ donors (A); Age-associated induction of TSP1 is attenuated, and OSKM sustained, in the absence of CD47 (B–G). Gene expression profiling by q-PCR of Thbs1 and Cd47 (A and B) and self-renewal factors OCT4, SOX2, KLF4, and cMYC (C–F) in aortas from young (3-month-old) and aged (18-month-old) mice. Error bars represent the mean ± SEM, samples in triplicate/mouse; 3-5 mice/group. Data normalized to 18srRNA gene. *p < 0.05, **p < 0.01, ***p < 001.

(2)

Cells 2020, 9, 1695 2 of 4

Supplementary Figure 2. Restoring CD47 in CD47-depleted ECs using TNF-α (50 ng/mL),middle lanes (A). Increasing CD47 levels rescues wildtype behavior in CD47-depleted 12 month old mouse aortic ECs (MAEC) (B, left graph), with representative JuLi™Br images on the right. CD47 delays restoration of endothelial scratch wounds (C), with representative images of endothelial cell mono-layer scratch wounds at 0 and 16 h.

(3)

Cells 2020, 9, 1695 3 of 4

Supplementary Figure 3. Comparison of angiogenic sprouting in human and mouse arteries under various conditions. Side-by-side comparison of angiogenic sprouting in arteries from older individuals treated with a CD47 antibody (2 μg/mL) or VEGF (50ng/mL) (A). TSP1 (2.2 nM) inhibited sprouting in aged mice arteries compared to controls (B) TSP1 was ineffective to inhibit the increased sprouting seen in aged CD47-null aortic rings (C) and side by side comparison of the results (B and C) in (D). Side-by-side comparison of results (C). Error bars represent the mean ± SEM. 3 wells/vessel, 3 subjects/group. Unpaired t-test between the matched groups of each day. *p < 0.05, **p < 0.01, ***p < 001.

(4)

Cells 2020, 9, 1695 4 of 4

Supplementary Figure 4

12

13

14

15

16

17

18

19

25

30

35

40

45

50

55

60

Time (months)

B

o

d

y

W

e

ig

h

t (

g

)

WT (SD)

WT (HFD)

CD47-/- (SD)

CD47-/- (HFD)

SD period

Supplementary Figure 4. Absence of CD47 retards HFD-induced weight gain with age. Body weight measurements of wild-type (WT) and CD47-null mice. All groups were on a standard diet (SD) until 14 months of age after which two groups (10 mice/group) were placed on the HFD and weight monitored until 19 months of age. Unpaired t-test between weight measurements of aged WT and CD47-null mice on the HFD, *p < 0.05, **p < 0.01, ***p < 001.

Références

Documents relatifs

We have shown that thin LCMO layers that are prepared with the A-type conditions (described in Table I ) exhibit a strong ferromagnetic response if grown directly on a LSAT

In your editorial, several examples were given in which the industry had pushed a product strongly into the market which turned out to be not beneficial or even harmful to the

Our goals were to instruct all of our users to perform tradeoff navigations using the example critiquing and ranked list interfaces respectively and to measure their task time and

After 64 days of treatments, shoot and root dry mass of plants treated with 100 mM, 150 mM, and 200 mM NaCl was significantly lower compared with the control, untreated plants (Table

Chronic increases in blood flow enhance arterial diameter and endothelium-dependent dilation.Since type 2 diabetes impairs endothelial sensitivity to flow

The same effect was observed in senescent MCF7 cells where p21waf1 inactivation also increased CIS escape and led to CD47 downregulation (supplementary Figure 8A–C).. This effect

the upregulation of myostatin also found in old Tg(Gasp-1) mice reveals that myostatin influences the metabolism of skeletal muscle, adipose tissue and liver,

The main findings of the present study are: 1) higher PP, PP/MBP, PPxHR and SBPxHR levels in middle-aged patients with type 1 diabetes compared with lean controls, in agreement